Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5985
    +0.0010 (+0.16%)
     
  • NZD/EUR

    0.5543
    +0.0010 (+0.19%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • NZD/JPY

    90.4590
    +0.0660 (+0.07%)
     

The Worldwide Sleeping Aids Industry is Expected to Reach $118 Billion by 2030

Company Logo
Company Logo

Global Sleeping Aids Market

Global Sleeping Aids Market
Global Sleeping Aids Market

Dublin, May 17, 2022 (GLOBE NEWSWIRE) -- The "Sleeping Aids Market Share, Size, Trends, Industry Analysis Report, By Product; By Sleep Disorders; By Region; Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global sleeping aids market size is expected to reach USD 118.31 billion by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing number of patient base suffering from respiratory issues, cardiovascular illnesses, and Obstructive Sleep Apnea (OSA), coupled with the rising occurrence of insomnia, are the primary factors that are likely to accelerate the industry demand across the globe. In addition, growing awareness regarding the accessibility of various sleeping aids and rising investments by the companies in the R&D activities are bolstering the industry growth across the globe. Moreover, factors such as rising consumption of alcohol and tobacco, sedentary lifestyle, stressful working hours are further attributed to the global industry demand in the forecasting years.

Based on the sleep disorders, the insomnia segment is dominating the global industry with the highest revenue shares owing to the irregular sleep schedule, stress, poor sleeping habits, and many others, coupled with the rising incidences of these disorders among the young and millennial population may lead to the segment demand. Whereas the sleep apnea segment is showing the highest CAGR rate that leads the industry demand. Factors such as the growing prevalence of patients affected with OSA (Obstructive Sleep Apnea), and growing awareness regarding the availability of various pills are fostering the global demand in the approaching years.

The growing prevalence of sleep apnea and insomnia among the population is a major health problem, which acts as a major driving factor for the industry's growth. For instance, as per the Sleep Foundation, nearly 10% to 30% of adults and 30% to 48% of older adults are suffering from insomnia. Additionally, narcolepsy is also an erratic disorder that can be treated and controlled with the help of sleep aids. Consequently, lack of sleep is decreasing productivity causes stress, depression, physical illnesses and pain, medications, and other neurological problems. Therefore, the industry is gaining huge traction among the population to cure their sleep disorders. Additionally, advancements in the types of sleeping aids such as mattresses and pillows are also propelling the global demand in the near future.

Market participants such as Natus Medical Incorporated, Biodiem, Cadwell Industries Inc., Compumedics Limited, CSL Limited, Devilbiss Healthcare, Drive, Emergent Biosolutions, F.Hoffmann-La Roche Ltd., Sleepmed Inc., Gamma Vaccines Pty Ltd., GlaxoSmithKline Plc, Koninklijke Philips N.V., Merck & Co., Inc., AstraZeneca Plc, Pfizer Inc., Sanofi, Sinovac Biotech Ltd., and Novartis AG are some of the key players operating in the global industry.

The frequent tactical movements such as mergers & acquisitions, product developments & launches, and others by the prominent industry players are supporting the global market development. For instance, in April 2021, Sandland Sleep introduced a new product, cannabinoid CBN-a, a natural, hemp-derived ingredient.

ADVERTISEMENT

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Sleeping Aids Market Insights
4.1. Sleeping Aids Market - Industry Snapshot
4.2. Sleeping Aids Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. The surge in cases of sleep disorders with changing lifestyle
4.2.1.2. Technological advancements
4.2.2. Restraints and Challenges
4.2.2.1. High cost of devices
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Sleeping Aids Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Sleeping Aids Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Sleeping Aids, by Product, 2018 - 2030 (USD Billion)
5.3. Mattresses & Pillows
5.3.1. Global Sleeping Aids Market, by Mattresses & Pillows, by Region, 2018 - 2030 (USD Billion)
5.4. Sleep Laboratories
5.4.1. Global Sleeping Aids Market, by Sleep Laboratories, by Region, 2018 - 2030 (USD Billion)
5.5. Medications
5.5.1. Global Sleeping Aids Market, by Medications, by Region, 2018 - 2030 (USD Billion)
5.5.2. Prescription-based Drugs
5.5.2.1. Global Sleeping Aids Market, by Prescription-based Drugs, by Region, 2018 - 2030 (USD Billion)
5.5.3. OTC drugs
5.5.3.1. Global Sleeping Aids Market, by OTC drugs, by Region, 2018 - 2030 (USD Billion)
5.5.4. Herbal drugs
5.5.4.1. Global Sleeping Aids Market, by Herbal drugs, by Region, 2018 - 2030 (USD Billion)
5.6. Sleep Apnea Devices
5.6.1. Global Sleeping Aids Market, by Sleep Apnea Devices, by Region, 2018 - 2030 (USD Billion)

6. Global Sleeping Aids Market, by Sleep Disorders
6.1. Key Findings
6.2. Introduction
6.2.1. Global Sleeping Aids Market, by Sleep Disorders, 2018 - 2030 (USD Billion)
6.3. Insomnia
6.3.1. Global Sleeping Aids Market, by Insomnia, by Region, 2018 - 2030 (USD Billion)
6.4. Sleep Apnea
6.4.1. Global Sleeping Aids Market, by Sleep Apnea, by Region, 2018 - 2030 (USD Billion)
6.5. Restless Legs Syndrome
6.5.1. Global Sleeping Aids Market, by Restless Legs Syndrome, by Region, 2018 - 2030 (USD Billion)
6.6. Narcolepsy
6.6.1. Global Sleeping Aids Market, by Narcolepsy, by Region, 2018 - 2030 (USD Billion)
6.7. Sleep Walking
6.7.1. Global Sleeping Aids Market, by Sleep Walking, by Region, 2018 - 2030 (USD Billion)
6.8. Others
6.8.1. Global Other Sleeping Aids Market, by Sleep Apnea, by Region, 2018 - 2030 (USD Billion)

7. Global Sleeping Aids Market, by Geography

8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/bxz1za

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900